0001567619-21-020888.txt : 20211119
0001567619-21-020888.hdr.sgml : 20211119
20211119180129
ACCESSION NUMBER: 0001567619-21-020888
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210908
FILED AS OF DATE: 20211119
DATE AS OF CHANGE: 20211119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones Erin
CENTRAL INDEX KEY: 0001754278
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38663
FILM NUMBER: 211429656
MAIL ADDRESS:
STREET 1: C/O GRITSTONE ONCOLOGY, INC.
STREET 2: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gritstone bio, Inc.
CENTRAL INDEX KEY: 0001656634
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 871-6100
MAIL ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: Gritstone Oncology, Inc.
DATE OF NAME CHANGE: 20151023
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2021-09-08
2021-09-10
0
0001656634
Gritstone bio, Inc.
GRTS
0001754278
Jones Erin
C/O GRITSTONE BIO INC.
5959 HORTON STREET, SUITE 300
EMERYVILLE
CA
94608
0
1
0
0
See Remarks
Common Stock
2021-09-08
4
M
0
2000
0.345
A
47900
D
Common Stock
2021-09-08
4
S
0
2000
11.3738
D
45900
D
Stock Option (Right to Buy)
0.345
2021-09-08
4
M
0
2000
0
D
2026-05-17
Common Stock
2000
35971
D
The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
Includes 25,900 Restricted Stock Units which are subject to vesting.
Fully exercisable.
Executive Vice President, Global Regulatory Affairs and Quality
/s/ Rahsaan Thompson, Attorney-in-Fact for Erin Jones
2021-11-19